Lv41
428 积分 2021-04-20 加入
An operational perturbation proteomics-based virtual cell model
1个月前
已完结
Artificial intelligence in drug discovery - what it is, where we stand and the path forward
2个月前
已完结
Charting intratumor heterogeneity from bench to bedside
2个月前
已完结
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
3个月前
已完结
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
4个月前
已完结
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial
5个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
5个月前
已完结
Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors
6个月前
已关闭
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design
6个月前
已完结
An agentic system for rare disease diagnosis with traceable reasoning
8个月前
已完结
皖公网安备34019202002308
